Bayer CropScience BAYERCROP
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Bayer CropScience's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
AI analysis and Advanced tools for BAYERCROP
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 5,699.4 | 5,245.9 | 4,597.1 |
| Accumulated Depreciation Total | -443.5 | -384.2 | -357.9 |
| Cash Equivalents | 1,399 | 878.7 | 1,022.8 |
| Other Liabilities Total | 127.4 | 110.2 | 125.3 |
| Accrued Expenses | 2.4 | 1.9 | 0.8 |
| Common Stock Total | 44.9 | 44.9 | 44.9 |
| Other Current Assets Total | 67.4 | 54.8 | 47.1 |
| Prepaid Expenses | 8.3 | 7 | 6.8 |
| Total Assets | 5,699.4 | 5,245.9 | 4,597.1 |
| Current Portof LT Debt/Capital Leases | 43 | 43.5 | 26.1 |
| Additional Paid-In Capital | 139.4 | 139.4 | 139.4 |
| Cash | 15.6 | 6.8 | 134 |
| Total Equity | 2,965.7 | 2,850.4 | 2,849.4 |
| Long Term Investments | 24.1 | 24.6 | 25.1 |
| Retained Earnings(Accumulated Deficit) | 2,781.4 | 2,666.1 | 2,665.1 |
| Total Common Shares Outstanding | 4.49 | 4.49 | 4.49 |
| Property/Plant/Equipment Total-Gross | 849.9 | 811.6 | 740.5 |
| Tangible Book Valueper Share Common Eq | 625.34 | 603.89 | 606.11 |
| Total Liabilities | 2,733.7 | 2,395.5 | 1,747.7 |
| Total Debt | 81.8 | 105.1 | 47.1 |
| Short Term Investments | 57.4 | 35.4 | 53.9 |
| Cashand Short Term Investments | 1,472 | 920.9 | 1,210.7 |
| Total Receivables Net | 1,171.1 | 1,090.4 | 1,055.1 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Accounts Receivable-Trade Net | 1,119 | 954.2 | 962.5 |
| Property/Plant/Equipment Total-Net | 406.4 | 427.4 | 382.6 |
| Total Current Liabilities | 2,567.5 | 2,223.7 | 1,597.4 |
| Total Inventory | 2,199.5 | 2,398.5 | 1,585.8 |
| Accounts Payable | 1,237.9 | 1,098.4 | 605.1 |
| Other Currentliabilities Total | 1,284.2 | 1,079.9 | 965.4 |
| Total Long Term Debt | 38.8 | 61.6 | 21 |
| Intangibles Net | 155.3 | 136.4 | 125.4 |
| Other Long Term Assets Total | 148.4 | 143.9 | 127.6 |
| Note Receivable-Long Term | 46.9 | 42 | 30.9 |
| Total Current Assets | 4,918.3 | 4,471.6 | 3,905.5 |
| Capital Lease Obligations | 38.8 | 61.6 | 21 |
| Deferred Income Tax | Not available | 0 | 4 |
Valuation and ratios
Growth
Debt 5Yr CAGR %25.48
Margins
Operating Margin 12m13.74
Operating Margin 5y Avg15.61
Net Profit Margin 12m12.14
Net Profit Margin 5y13.02
Yield
Dividend Yield %3.49
Valuation
Price to Sale Ratio3.33
Source-qualified signals
Risk metrics
Overall RiskModerate risk
Board Risk24.52
Analyst consensus
ConsensusBuy
Consensus score2.38
Analyst opinions8
Strong Sell count0
Sell count0
Hold count4
Buy count3
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,749 | 2.64 L | 58.09 | — |
| Solar Industries India | INR 18,560 | 1.68 L | 99.61 | — |
| Pidilite Industries | INR 1,671 | 1.70 L | 64.76 | — |
| SRF | INR 2,626 | 77,841.16 | 44.57 | — |
| Linde India | INR 7,105 | 61,033.66 | 110.53 | — |
Ownership
- Promoter
- 71.43%
- FII
- 3.97%
- MF
- 9.23%
- Other
- 15.37%
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Bayer CropScience Limited Submits 68th Annual Report for Financial Year 2025-26 scanx.trade
Bayer stock trades resiliently as crop science and pharmaceuticals underpin earnings Ad-hoc-news.de
Bayer stock trades steady as investors weigh Crop Science headwinds and pharma pipeline Ad-hoc-news.de
Bayer stock trades steady as investors weigh litigation risks and crop science earnings Ad-hoc-news.de
Bayer stock trades steady as crop science and pharma outlook hinge on debt reduction ad-hoc-news.de
Bayer stock trades steady as crop science and pharmaceuticals shape outlook ad-hoc-news.de
Events
- annual General MeetingAGM
- dividendRs.60.0000 per share(600%)Final Dividend
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- dividendRs.90.0000 per share(900%)Interim Dividend
- board MeetingsQuarterly Results & Interim Dividend
- annual General MeetingAGM
- dividendRs.35.0000 per share(350%)Final Dividend
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
- board MeetingsQuarterly Results
- dividendRs.90.0000 per share(900%)Interim Dividend
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsQuarterly Results
- dividendRs.35.0000 per share(350%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
Discussion and sentiment for Bayer CropScience
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Community discussion loads as you approach this section.
Business information
What the company does
Bayer CropScience Limited is an India-based company, which is engaged in the manufacturing, sale and distribution of insecticides, fungicides, herbicides and various other agrochemical products and corn seeds. The Company operates through the Agri Care segment. The Company’s operations include three business areas: Crop Protection, Seeds & Traits and Digital Farming. Its Crop Protection portfolio comprises a wide range of chemical and biological pest management solutions. Its Seeds & Traits develops seeds and traits that provide farmers with new solutions. Its Digital Farming consists of modern farming methods that use technology to improve crop yield and efficiency while reducing waste and environmental impact. The Company offers various brands, such as Alion Plus, Movento Energy, Solomon, Lesenta, Nativo, Permethrin, Sectin, Topstar, and others.
Company facts
- Industry
- Chemical Manufacturing
- Sector
- Chemical Manufacturing
- NSE Code
- BAYERCROP
- BSE Code
- 506285
Stock FAQ
What is the symbol and ISIN of Bayer CropScience?
Bayer CropScience has the symbol BAYERCROP and ISIN - INE462A01022.
What is the latest recorded price of Bayer CropScience?
The latest available recorded price of Bayer CropScience is INR 4,215.50 as of 2026-08-06T20:53:38.268Z. This is a source-stamped snapshot, not a live quote.
What are the year high and year low of Bayer CropScience?
Year high: INR 6,539.95. Year low: INR 4,030.00.
What is the market capitalization of Bayer CropScience?
Market capitalization: INR 18,921.50 crore.
What is the P/E ratio of Bayer CropScience?
P/E ratio: 30.29.
What is the dividend yield of Bayer CropScience?
Dividend yield: 3.49%.
How is the financial performance of Bayer CropScience based on revenue, net income, and EPS?
Revenue: INR 5,675.00 crore. Net income: INR 689.20 crore. EPS: INR 153.35.
What is the book value of Bayer CropScience?
Book value: INR 625.34.
What are the price-to-book and price-to-sales ratios of Bayer CropScience?
Price-to-book ratio: 6.74. Price-to-sales ratio: 3.33.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.